Replication fidelity uses successive discrimination and repair systems, because no single enzyme detects every error. The important distinctions are between an incorrect base pair, a slipped sequence register, the wrong sugar incorporated into DNA, a damaged template and an incompletely or incorrectly restored chromosome. Repair must also identify which information should be retained: recognizing a mismatch without strand discrimination could fix the wrong sequence.
A polymerase can select an incorrect deoxynucleoside triphosphate and insert the wrong base through imperfect discrimination, transient base configurations or an altered active site environment. If the mismatch is extended and survives into another replication round, it can become a stable base substitution. Many replicative polymerases possess a separate 3′→5′ exonuclease proofreading site. A mismatched primer end tends to slow extension and transfer toward this site; removal of the terminal nucleotide permits another attempt at correct synthesis. This is distinct from the polymerase's forward synthetic reaction and from proofreading in biological translation. In mice, selective disruption of DNA polymerase δ proofreading increased mutation and tumour susceptibility, demonstrating an organismal consequence of unrepaired copying errors.[ref]
Post-replicative DNA mismatch repair corrects many errors that escape the polymerase. In eukaryotes, MutSα, formed by MSH2 and MSH6, recognizes base mismatches and many short insertion–deletion loops; MutSβ, containing MSH2 and MSH3, has an important role in larger loops. Recruitment of MutL complexes, strand incision, excision, resynthesis and ligation replaces a stretch of the newly synthesized strand. Nascent-strand discontinuities and replication-associated factors including PCNA help direct the process. Purified human activities reconstituted nick-directed repair from defined substrates, showing how a mismatch and a strand-break signal can support directional replacement.[ref] The classic Escherichia coli MutH system instead uses transiently undermethylated daughter DNA at suitable sites; that methyl-directed mechanism is not a universal description of eukaryotic DNA mismatch repair or even of every bacterium.
replication slippage creates a different substrate. In repetitive sequence, transient misalignment can leave an extra loop in the nascent or template strand. A retained nascent-strand loop can produce an insertion; copying past a looped-out template segment can produce a deletion. Short repeats are therefore vulnerable to length changes, and coding-region insertions or deletions can cause a frameshift if their length is not a multiple of three. DNA mismatch repair recognizes many such loops, although substrate size and structure affect efficiency. Yeast mismatch-repair mutants destabilized simple repetitive tracts, linking repair defects with microsatellite instability.[ref] This is a DNA-sequence frameshift mechanism, distinct from a ribosome changing reading frame during biological translation.
The layers can be represented by conditional escape probabilities,
where the second and third factors refer to escape among errors reaching the corresponding stage. As a purely illustrative calculation, per copied base. These are not asserted universal measured rates: mismatch identity, sequence, polymerase and repair state all matter. The multiplicative logic explains why disabling a later layer can reveal errors that had previously escaped detection without eliminating DNA synthesis itself.
Polymerases can also incorporate a ribonucleotide instead of a deoxyribonucleotide. base pairing may be correct, so ordinary mismatch recognition is insufficient. RNase H2 can initiate ribonucleotide excision repair by incising near an embedded ribonucleotide, followed by DNA synthesis, removal of the displaced segment and ligation. Reconstitution established this dedicated pathway.[ref] RNase H1 processing of an RNA–DNA hybrid should not be equated with removal of a single isolated ribonucleotide. Separately, normal RNA primers on Okazaki fragments must be processed and the remaining nicks sealed; persistent primers, flaps or unligated junctions threaten chromosome integrity even without an incorrect base.
A chemically damaged template can miscode or stall a fork. Small base lesions can be addressed by base excision repair, whereas nucleotide excision repair removes a damaged oligonucleotide around many bulky, helix-distorting lesions. These pathways repair chemical damage, not every mismatch made on an undamaged template. Replication across an oxidized base can require coordinated recognition of the lesion and the incorrectly paired partner so that repair does not convert damage into a fixed mutation. translesion synthesis permits passage across some lesions with specialized polymerases; it is damage tolerance, not necessarily lesion removal or error-free copying. template switching can provide another route around a block.
Stalled or collapsed forks can leave gaps, broken DNA and structural rearrangements. homologous recombination can use a sister chromatid to restore information and restart appropriate substrates; inappropriate pairing or template switching can instead change sequence organization. non-homologous end joining can restore continuity after a break but need not preserve every base, particularly when end processing is required. Replication checkpoints help stabilize forks and delay progression, while under-replication or rereplication requires control of origin use as well as lesion processing. Numerical chromosome-segregation errors are a related genome-stability problem but are not corrected by simply excising one mismatched base. Base selectivity and proofreading act during synthesis, mismatch and ribonucleotide repair address distinct residual substrates, and damage/fork-repair pathways restore templates and continuity with different fidelity limits.
Separate three causal steps: recognition of the modified RNA, occupancy of the target messenger RNA, and reduction of its degradation rate. Call the newly identified RNA-binding protein R. Its recovery in a screen need not mean it contacts the modified ribonucleotide directly; it could recognize a modification-dependent structure or arrive through another protein. Likewise, more target messenger RNA could reflect increased transcription rather than greater stability.
First reproduce the interaction using endogenous R and the endogenous target. Determine R's protein domains, expression and subcellular distribution, then use reciprocal RNA immunoprecipitation and crosslinking and immunoprecipitation to locate the occupied region. Normalize enrichment to input target abundance and R recovery, and include unrelated RNAs, a non-specific antibody and cells lacking R. Crosslink-based occupancy supports close contact, whereas recovery without crosslinking can preserve indirect complexes. Determine whether the relevant modification actually occurs near the binding site: mass spectrometry of purified target fragments can establish chemical identity, supplemented by a modification-specific mapping assay with known modified and unmodified standards. Bulk mass spectrometry of all cellular RNA cannot assign a modification to this particular transcript or position. Do not assume the modification is N6-methyladenosine merely because it is familiar.
Prepare short synthetic RNAs identical in nucleotide sequence, length, ends and labelling except for the single modified ribonucleotide. Measure binding of purified R over a concentration range by electrophoretic mobility shift assay or fluorescence anisotropy, with competition by unlabelled cognate and unrelated RNA. The dissociation constant distinguishes a quantitative preference from a binary pull-down impression. Verify that R is folded and sufficiently pure; include an RNA-binding-defective R mutant, several surrounding sequences and different modification positions. Modification-specific recovery from a cellular extract can disappear with purified R, revealing a missing partner rather than disproving the original screen.
Distinguish chemical recognition from structural recognition. Compare RNA secondary structure with and without the modification by RNA structure probing. Then disrupt the stem without changing the binding motif, or restore pairing through compensatory mutations. If an unmodified but constitutively exposed motif binds R, and restoring occlusion suppresses binding even when the modification remains, an RNA modification switch is plausible. Direct recognition is supported when modification discrimination persists after accessibility is matched and is lost upon a specific R binding-pocket mutation. Structural work can identify the contacts, but binding and structure controls remain essential. Modification-dependent exposure of a binding motif has an experimental precedent in the N6-methyladenosine-dependent RNA modification switch for HNRNPC.[ref]
Establish stability by acute depletion of R, followed by a metabolic RNA labelling pulse and chase. Measure loss of labelled target molecules using appropriate spike-ins and a time course spanning the expected half-life, while independently estimating newly synthesized target RNA. SLAM-seq is one possible implementation: chemical treatment makes incorporated 4-thiouridine detectable through characteristic sequencing changes.[ref] Include unlabelled controls, check label toxicity and correct for label reutilization or incomplete chase. When reporting molecules per biological cell, separate dilution through increasing cell number from chemical degradation. A transcription inhibitor time course provides an orthogonal check, but broad inhibition itself can change decay. Under a constant first-order degradation model, labelled molecules obey
A shorter half-life after R depletion, reversed by normal R but not its RNA-binding-defective mutant, establishes the proposed effect. Allow a more complex fit if the exponential decay model is inconsistent with the measured time course. At steady state, abundance is synthesis rate divided by degradation rate, so abundance alone cannot identify which rate changed.
Use a controlled target reporter gene carrying the occupied region, then remove or mutate that region and measure reporter messenger RNA decay. Preserve polyadenylation, RNA splicing and coding potential where possible, and distinguish site loss from altered RNA secondary structure. Manipulate the relevant modification-producing enzyme acutely, rescuing with normal or catalytically inactive enzyme; verify target-site modification after the manipulation. Cross the two perturbations: if R stabilizes the target specifically through the modification, removing the modification should reduce R occupancy and eliminate or substantially weaken the extra effect of removing R. This epistasis supports a shared pathway, but floor effects or redundant sites can obscure it. A site-specific chemically modified reporter helps separate local recognition from the many indirect consequences of removing a global modification enzyme.
Identify the affected decay step using poly(A) tail measurements, cap-state assays and mapping of decay intermediates. Test whether R excludes a microRNA-loaded Argonaute complex or a decay-promoting RNA-binding protein, blocks an endonuclease, inhibits deadenylation or decapping, or recruits a protective partner such as poly(A)-binding protein. Use protein interaction analysis with and without ribonuclease to distinguish RNA-bridged association from a more direct interaction. R mutants that retain target binding but lose a partner interaction separate recruitment from recognition. Depleting the implicated decay factor should suppress the destabilization caused by R loss; purified-system decay assays can test whether R alone physically protects the substrate.
Measure biological translation and subcellular location in parallel, using ribosome profiling or a controlled biological translation reporter and single-molecule fluorescence in situ hybridization. R might stabilize the target indirectly by altering ribosome loading or compartment access. Inhibiting biological translation can itself alter decay, and colocalization in a granule does not establish protection. The reported stabilizing action of IGF2BP proteins on modified targets provides a candidate mechanism to compare with, rather than an identity to assign to R.[ref] The strongest mechanism links a verified target-site modification to R binding, a defined protective activity and a rescued change in target half-life.
Repair of ribonucleotides embedded in DNA, including molecules with correct base pairing. RNase H2 can initiate an incision followed by replacement synthesis and ligation.[ref]
RNase H1 2026-10-20
An enzyme acting on appropriate RNA–DNA hybrid substrates. Its substrate requirements differ from removal of a single isolated ribonucleotide by RNase H2.
RNase H2 2026-10-20
A ribonuclease H system capable of recognizing a single ribonucleotide embedded in DNA and initiating its removal. This substrate is distinct from a longer RNA–DNA hybrid.
Transcription start site 2026-10-20
The DNA position corresponding to the first incorporated ribonucleotide in a primary transcript. A processed end need not identify a transcription start site.